Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
| Revenue (Most Recent Fiscal Year) | $3.37B |
| Net Income (Most Recent Fiscal Year) | $113.10M |
| PE Ratio (Current Year Earnings Estimate) | 15.21 |
| PE Ratio (Trailing 12 Months) | 15.85 |
| PEG Ratio (Long Term Growth Estimate) | 2.50 |
| Price to Sales Ratio (Trailing 12 Months) | 1.64 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.08 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 10.38 |
| Pre-Tax Margin (Trailing 12 Months) | 4.65% |
| Net Margin (Trailing 12 Months) | 2.31% |
| Return on Equity (Trailing 12 Months) | 19.47% |
| Return on Assets (Trailing 12 Months) | 5.95% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.57 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.74 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 1.13 |
| Inventory Turnover (Trailing 12 Months) | 1.54 |
| Book Value per Share (Most Recent Fiscal Quarter) | $12.10 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.47 |
| Earnings per Share (Most Recent Fiscal Year) | $2.41 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.52 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 151.53M |
| Free Float | 110.16M |
| Market Capitalization | $5.65B |
| Average Volume (Last 20 Days) | 2.57M |
| Beta (Past 60 Months) | 1.23 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 27.30% |
| Percentage Held By Institutions (Latest 13F Reports) | 79.52% |
| Annual Dividend (Based on Last Quarter) | $0.20 |
| Dividend Yield (Based on Last Quarter) | 0.54% |